Yitian Xu

8PUBLICATIONS
78CO-AUTHORS
Haematological tumoursInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 07, 2024
Characterization of the Breast Cancer Liver Metastasis Microenvironment via Machine Learning Analysis of the Primary Tumor Microenvironment.

Dylan A Goodin, Eric Chau, Junjun Zheng

|Dec 15, 2023
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.

Sunny Mai, Alan Hodges, Hui-Ming Chen

|Mar 16, 2023
Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell Profiles.

Yitian Xu, Licheng Zhang, Jose Thaiparambil

|Jul 25, 2022
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.

Kai Sun, Yitian Xu, Licheng Zhang

|Apr 20, 2022
Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer.

Swarnima Singh, Nigel Lee, Diego A Pedroza

|Dec 15, 2021
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.

Andrew W Chung, Kartik Anand, Ann C Anselme

Pageof 2

Frequent Collaborators

5 joint publications

Shu-Hsia Chen

4 joint publications

Licheng Zhang

3 joint publications

Polly Niravath

3 joint publications

Ping-Ying Pan